The collapse of EBIT: Dräger with less profit in the second quarter | message

The operating profit (EBIT) has plummeted from 16.8 million to about 3 million euros, the manufacturer of medical and security technologies said Friday. Another reason Dr. Drgerwerk called a "negative mix of products," which had encumbered the gross margin. Sales rose 6.7% to about 620 million euros, or 10.1% at constant exchange rates. Negative currency effects also weighed on new orders, down 1.6%.

The Group nevertheless confirms its forecasts for the current financial year. Drgerwerk continues to anticipate a 2 to 5% currency adjusted turnover growth and an EBIT margin between 4.0 and 6.0%. That would probably be in the lower range of the forecast range, the company said.

Drgerwerk intends to submit the complete figures on July 26th. The stock price of the company did not first respond to the news./nas/he

LBECK (dpa-afx)

Sources of the Image: Drgerwerk AG, Drgerwerk